Source comparison
CJC-1295/Ipamorelin Protocol Comparison
Single Evening Dose Once daily before bed Aligns with natural nocturnal GH surge; minimises daytime cortisol interference 35–50% above baseline Users prioritising sleep quality and recovery; those with daytime work constraints Most sustainable long-term. Mimic
This comparison does not assign a generated winner or score.
- Single Evening Dose
- Once daily before bed
- Aligns with natural nocturnal GH surge; minimises daytime cortisol interference
- 35–50% above baseline
- Users prioritising sleep quality and recovery; those with daytime work constraints
- Most sustainable long-term. Mimics natural physiology closely
- Twice-Daily Dosing
- Morning fasted + evening pre-sleep
- Amplifies both circadian GH peaks (morning post-waking, night during sleep)
- 50–70% above baseline
- Users targeting maximal body composition changes; research use
- Higher efficacy but requires stricter meal timing and injection discipline
- EOD High-Dose
- Every other day, evening only
- Allows receptor recovery between doses; may reduce desensitisation risk
- 40–55% above baseline (averaged)
- Users concerned about long-term receptor sensitivity; cost management
- Theoretical benefit unproven. Daily dosing shows better outcome consistency in published trials